slight clouding of consciousness with focal
neurological signs such as cranial nerve palsies or
hemiparesis. In advanced clinical stages, TBM
presents severe clouding of consciousness or
delirium, convulsions, and serious neurological signs
such as hemiplegia, paraplegia, involuntary
movement (Israni, et al., 2016).
Tuberculin skin test (Mantoux test) may be
nonreactive in 50% cases of CNS TB. Hence, it is
helpful in supporting the diagnosis of TBM when
positive, but an isolated positive Mantoux cannot be
used to label a case of TBM, as false positive/false
negative reactions are commonly known (Aulakh &
Chopra, 2018).
Tuberculous meningitis usually presents with a
Cerebrospinal fluid (CSF) of 10–500 cells/μL that are
polymorphs initially and lymphocytes later. A low
glucose <40 mg/dL (rarely<20 mg/dL) or a
CSF/plasma glucose ratio <50% or a high-protein
content (400–5000 mg/dL) is suggestive of the
diagnosis of TBM. The CSF lactate levels are usually
raised to 5–10 mmol/L (normal range, 1.2–2.1
mmol/L). Ziehl–Neelsen (ZN) staining for the smear
examination has a sensitivity of approximately 50%,
whereas a bacterial culture has a sensitivity of 60% to
70% (Aulakh & Chopra, 2018). CT scanning and
MRI of the brain may reveal hydrocephalus, basilar
meningeal enhancement, infarcts, edema, and
tuberculomas (Toorn & Solomons, 2014).
This patient presented with a decreased level of
consciousness, headache, nuchal rigidity, positive
Babinski sign, right hemiparesis. TB IGRA was
positive in this patient. He previously complained of
cough and fever for two weeks and weight loss for 1
month.
Chest X-ray also showed miliary tuberculosis,
and the CT of the Brain showed mild hydrocephalus
which suggests meningitis. From the clinical
examination, diagnostic tests, this patient can be
categorized into stage 2 of TBM.
WHO recommends a 12-month treatment plan
(2RHZE/10RH) for children with suspected or
confirmed TBM (Toorn & Solomons, 2014). We
gave anti-tuberculosis drugs to this patient according
to the WHO guideline. Meropenem was given due to
the possibility of bacterial meningitis that is evidently
suggested by leukocytosis and increased neutrophil
count. Hyponatremia occurs in up to 85% of children
with TBM and is thought to be secondary to either
syndrome of inappropriate antidiuretic hormone or
cerebral salt wasting. We also found hyponatremia in
this patient which was treated with normal saline
fluid. Corticosteroid oral was given to reduce the risk
of death and neurological deficit (Toorn &
Solomons, 2014).
The patient showed clinical improvement in his
motoric function after being given an anti-
tuberculosis drug regimen, oral corticosteroid, and
physiotherapist.
4 CONCLUSION
Patients with TBM develop typical symptoms and
signs of meningitis including headache, fever, and
stiff neck, although meningeal signs may be absent
in the early stage. The duration of symptoms before
presentation ranges from several days to several
months. In particular, in resource-limited settings,
TBM cases may present in advanced clinical stages,
with GCS scores of 10 or less. Cranial nerve palsies,
hemiparesis, paraparesis, and seizures are common
and should raise the possibility of tuberculous
meningitis as the etiology of meningitis (Chin,
2014).
This case shows that clinical symptoms of
tuberculous meningitis can appear as hemiparesis
without a seizure. Proper treatment of tuberculous
meningitis may lead to a better outcome.
REFERENCES
Aulakh, R., & Chopra, S. (2018). Pediatric tubercular
meningitis : A review. J Pediatr Neurosci, 13:373-
82.
Chin, J. H. (2014, June). Tuberculous Meningitis.
Neurol Clin Pract, 4(3):199-205.
doi:10.1212/CPJ.0000000000000023.
Israni, A. V., Dave, D. A., Mandal, A., Ranjan, R. D.,
Singh, A., & Sahi, P. K. (2016). Tubercular
meningitis in children: Clinical, pathological, and
radiological profile and factors associated with
mortality. J Neurosci Rural Pract, 7(3):400-404.
doi:10.4103/0976-3147.181475.
Rohlwink, U. K., Donald, K., Gavine, B., Padayachy, L.,
Wilmshurst, J. M., Fieggen, G. A., & Figaji, A. A.
(2016). Clinical characteristics and
neurodevelopmental outcomes of children with
tuberculous meningitis and hydrocephalus.
Developmental Medicine & Child Neurology,
58:461-468.
Toorn, R. v., & Solomons, R. (2014). Update on the
Diagnosis and Management of Tuberculous
Meningitis in Children. Semin Pediatr Neurol,
21:12-18.
Torok, M. (2015, March). Tuberculous meningitis :
advance in diagnosis and treatment. Br Med Bull,
113(1):117-31. doi:10.1093/bmb/ldv003.
WHO. (2018). Global Tuberculosis Report 2018.
Geneva: World Health Organization.